BioCentury | Aug 1, 2018
Translation in Brief

New Therapeutic Targets and Biomarkers: July 2018

...Distillery Techniques Kinesin family member 3b (KIF3B) Translation in Brief Non-small cell lung cancer (NSCLC) Cbl proto-oncogene C (CBLC)...
BioCentury | Jul 17, 2018
Distillery Therapeutics


...mutation, for NSCLC and has the drug in Phase I testing for solid tumors. TARGET/MARKER/PATHWAY: Cbl proto-oncogene C (CBLC)...
Items per page:
1 - 2 of 2